Anesthesiology and Pain Medicine

Published by: Kowsar

Effect of Local Fibrinogen Administration on Postoperative Bleeding in Open Prostatectomy Surgery

Farahzad Janatmakan 1 , Nozar Nassajian 1 , Mohsen Sarkarian 2 , Mohammadreza Ghandizadeh Dezfuli 1 , * , Amir Salari 1 , Seyed Kamaleddin Tabatabaei 1 , Farhad Soltani 1 and Sheida Nassajian 1
Authors Information
1 Department of Anesthesia, Pain Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Urology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Anesthesiology and Pain Medicine: 8 (3); e73983
  • Published Online: June 29, 2018
  • Article Type: Research Article
  • Received: April 28, 2018
  • Revised: June 18, 2018
  • Accepted: June 23, 2018
  • DOI: 10.5812/aapm.73983

To Cite: Janatmakan F, Nassajian N, Sarkarian M, Ghandizadeh Dezfuli M, Salari A, et al. Effect of Local Fibrinogen Administration on Postoperative Bleeding in Open Prostatectomy Surgery, Anesth Pain Med. Online ahead of Print ; 8(3):e73983. doi: 10.5812/aapm.73983.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014;370(10):932-42. doi: 10.1056/NEJMoa1311593. [PubMed: 24597866]. [PubMed Central: PMC4118145].
  • 2. Safir I, Sanda M, Patil D, Crociani C, Hembroff L, Wei J, et al. Mp76-06 Use and Effectiveness of Pharmacologic and Non-Pharmacologic Erectile Aids among Post-Prostatectomy Prostate Cancer Survivors Seeking Treatment for Erectile Dysfunction: A Prospective, Multicenter Study. J Urol. 2016;195(4):e1008-9. doi: 10.1016/j.juro.2016.02.1857.
  • 3. Boehm K, Beyer B, Tennstedt P, Schiffmann J, Budaeus L, Haese A, et al. No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer. World J Urol. 2015;33(6):801-6. doi: 10.1007/s00345-014-1351-0. [PubMed: 24989847].
  • 4. Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet. 2003;361(9353):201-5. doi: 10.1016/S0140-6736(03)12268-4. [PubMed: 12547542].
  • 5. Nash PA, Schrepferman CG, Rowland RG, Young J, Foster RS, Birhle R, et al. The impact of pre-donated autologous blood and intra-operative isovolaemic haemodilution on the outcome of transfusion in patients undergoing radical retropubic prostatectomy. Br J Urol. 1996;77(6):856-60. [PubMed: 8705221].
  • 6. Pourfakhr P, Gatavi E, Gooran S, Etezadi F, Khajavi MR, Pourroustaei R, et al. Local Administration of Tranexamic Acid During Prostatectomy Surgery: Effects on Reducing the Amount of Bleeding. Nephrourol Mon. 2016;8(6). e40409. doi: 10.5812/numonthly.40409. [PubMed: 27896241]. [PubMed Central: PMC5120251].
  • 7. Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A, et al. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc. 2015;4(6). e002066. doi: 10.1161/JAHA.115.002066. [PubMed: 26037084]. [PubMed Central: PMC4599543].
  • 8. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem. 2005;70:247-99. doi: 10.1016/S0065-3233(05)70008-5. [PubMed: 15837518].
  • 9. Hayakawa M, Sawamura A, Gando S, Kubota N, Uegaki S, Shimojima H, et al. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase. Surgery. 2011;149(2):221-30. doi: 10.1016/j.surg.2010.06.010. [PubMed: 20655560].
  • 10. Martini WZ, Chinkes DL, Pusateri AE, Holcomb JB, Yu YM, Zhang XJ, et al. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. Am J Physiol Endocrinol Metab. 2005;289(5):E930-4. doi: 10.1152/ajpendo.00137.2005. [PubMed: 15956050].
  • 11. Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol. 2000;54(3):260-4. discussion 264-5. [PubMed: 11118574].
  • 12. Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke. 2002;33(6):1618-23. [PubMed: 12053001].
  • 13. Godje O, Gallmeier U, Schelian M, Grunewald M, Mair H. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg. 2006;54(1):26-33. doi: 10.1055/s-2005-872853. [PubMed: 16485185].
  • 14. Fenger-Eriksen C, Ingerslev J, Sorensen B. Fibrinogen concentrate--a potential universal hemostatic agent. Expert Opin Biol Ther. 2009;9(10):1325-33. doi: 10.1517/14712590903193051. [PubMed: 19645632].
  • 15. Kreuz W, Meili E, Peter-Salonen K, Haertel S, Devay J, Krzensk U, et al. Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfus Apher Sci. 2005;32(3):247-53. doi: 10.1016/j.transci.2004.08.003. [PubMed: 15919240].
  • 16. Levy JH, Goodnough LT. How I use fibrinogen replacement therapy in acquired bleeding. Blood. 2015;125(9):1387-93. doi: 10.1182/blood-2014-08-552000. [PubMed: 25519751].
  • 17. Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol. 1997;97(4):775-84. [PubMed: 9217176].
  • 18. Agger P, Langhoff J, Smerup MH, Hasenkam JM. Comparison between TachoComb and TachoSil for surgical hemostasis in arterial bleeding: an animal experimental study. J Trauma. 2010;68(4):838-42. doi: 10.1097/TA.0b013e3181b1388c. [PubMed: 20386279].
  • 19. Alizadeh Ghavidel A, Mirmesdagh Y, Samiei N, Gholampour Dehaki M. Haemostatic Role of TachoSil Surgical Patch in Cardiac Surgery. J Cardiovasc Thorac Res. 2014;6(2):91-5. doi: 10.5681/jcvtr.2014.020. [PubMed: 25031823]. [PubMed Central: PMC4097858].
  • 20. Payani N, Foroughi M, Rajaei S, Dabbagh A. Effect of local fibrinogen administration on postoperative bleeding in coronary artery bypass graft patients. J Cell Mol Anesthes. 2016;1(1):23-7.
  • 21. Han M, Partin AW, Wein AJ, Kavoussi LR, Novick AC, Peters CA. Campbell-Walsh urology. 2007.
  • 22. Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion. 2008;48(10):2152-8. doi: 10.1111/j.1537-2995.2008.01827.x. [PubMed: 18657083].
  • 23. Capraro L. Transfusion practices in elective surgical procedures in finnish hospitals. 2001.
  • 24. Heyse TJ, Haas SB, Drinkwater D, Lyman S, Kim HJ, Kahn BA, et al. Intraarticular fibrinogen does not reduce blood loss in TKA: a randomized clinical trial. Clin Orthop Relat Res. 2014;472(1):272-6. doi: 10.1007/s11999-013-3036-1. [PubMed: 23657879]. [PubMed Central: PMC3889440].
  • 25. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth. 2008;101(6):769-73. doi: 10.1093/bja/aen270. [PubMed: 18818192].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments